COVID-19: FDA Schedules 5 More Virtual Town Halls Through September
Executive Summary
The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.
You may also be interested in...
US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight
US FDA staff spoke on HHS’s new laboratory developed test edict, as well as ongoing concerns around new test types and reviewer responsiveness in a recent virtual town hall.
FDA Extends On-Site Surveillance Inspections Freeze Another 2 Weeks Because Of Omicron
The US agency had previously decided to halt domestic inspections through at least 19 January because of the COVID-19 Omicron variant. But now that timeline has been lengthened.